2021-01-05,Sierra Oncology to Present at H.C. Wainwright 2021 BioConnect Virtual Conference
2021-01-05,Sierra Oncology to Present at H.C. Wainwright 2021 BioConnect Virtual Conference
2020-12-15,IIROC Trading Resumption - LUCK
2020-12-11,Is SRRA A Good Stock To Buy Now?
2020-12-07,Sierra Oncology Announces Momelotinib Data for Intermediate / High-risk Myelofibrosis Patients with Lower Baseline Platelet Counts
2020-12-07,Sierra Oncology Announces Momelotinib Data for Intermediate / High-risk Myelofibrosis Patients with Lower Baseline Platelet Counts
2020-12-05,Sierra Oncology Presents Long-term Overall Survival and Sustained Efficacy Outcomes Data for Momelotinib at ASH Annual Meeting
2020-12-05,Sierra Oncology Presents Long-term Overall Survival and Sustained Efficacy Outcomes Data for Momelotinib at ASH Annual Meeting
2020-12-01,Sierra Oncology to Host KOL Panel Event to Discuss Updated Phase 3 Myelofibrosis Data Presented at ASH
2020-12-01,Sierra Oncology to Host KOL Panel Event to Discuss Updated Phase 3 Myelofibrosis Data Presented at ASH
2020-11-25,Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
2020-11-18,"Who Has Been Buying Sierra Oncology, Inc. (NASDAQ:SRRA) Shares?"
2020-11-12,Sierra Oncology to Present at 2020 Jefferies Virtual London Healthcare Conference
2020-11-05,Sierra Oncology to Report Momelotinib Long-term Overall Survival Data in Oral Presentation at ASH 2020
2020-11-05,Sierra Oncology to Report Momelotinib Long-term Overall Survival Data in Oral Presentation at ASH 2020
2020-11-05,Sierra Oncology Reports Third Quarter 2020 Results
2020-10-02,Sierra Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-10-02,Sierra Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-09-14,Sierra to Present at September Investor Conferences
2020-09-14,Sierra to Present at September Investor Conferences
2020-09-04,"What You Need To Know About Sierra Oncology, Inc.'s (NASDAQ:SRRA) Investor Composition"
2020-08-06,Sierra Oncology Strengthens Management Team to Implement North American Pre-Commercialization Strategy for Momelotinib
2020-08-06,Sierra Oncology Reports Second Quarter 2020 Results
2020-07-28,Sierra Oncology Appoints Christina Thomson as General Counsel
2020-06-26,"Sierra Oncology, Inc. (SRRA): Hedge Funds In Wait-and-See Mode"
2020-06-18,"Sierra Oncology, Inc (SRRA) Upgraded to Buy: What Does It Mean for the Stock?"
2020-06-16,Codexis Announces the Election of New Directors at its Annual Meeting of Stockholders
2020-06-12,Sierra Oncology Reports Favorable Long-Term Safety and Dose Intensity Data for Momelotinib
2020-06-12,Sierra Oncology Reports Favorable Long-Term Safety and Dose Intensity Data for Momelotinib
2020-05-27,Sierra Oncology Announces Presentations at Upcoming Investor Conferences
2020-05-27,Sierra Oncology Announces Presentations at Upcoming Investor Conferences
2020-05-26,Sierra Oncology Appoints Dr. Stephen Dilly as President and Chief Executive Officer
2020-05-26,Sierra Oncology Appoints Dr. Stephen Dilly as President and Chief Executive Officer
2020-05-14,Sierra Oncology to Report Favorable Dose Intensity Data and Long-Term Safety Data for Momelotinib at the 25th European Hematology Association (EHA) Congress
2020-05-07,Sierra Oncology to Hold KOL Call to Discuss Anemia & Transfusion Dependency as Critical Unmet Needs in Myelofibrosis
2020-05-07,Sierra Oncology to Hold KOL Call to Discuss Anemia & Transfusion Dependency as Critical Unmet Needs in Myelofibrosis
2020-05-07,Sierra Oncology Reports First Quarter 2020 Results
2020-05-04,Here's Why We're Not Too Worried About Sierra Oncology's (NASDAQ:SRRA) Cash Burn Situation
2020-04-21,Keros Therapeutics Shares Climb 70% After First Post-Covid-19 Biotech IPO
2020-03-03,Sierra Oncology Reports 2019 Year End Results
2020-02-26,Why Earnings Season Could Be Great for Sierra Oncology (SRRA)
2020-02-26,Sierra Oncology to Hold Year End 2019 & 2020 Outlook Analyst & Investor Call
2020-02-25,Sierra Oncology to Present at the Cowen 40th Annual Health Care Conference
2020-02-11,"The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology"
2020-02-06,Sierra Oncology Completes Conversion of Preferred to Common Stock and Issues Stock to Gilead
2020-01-28,Sierra Oncology Sees Hammer Chart Pattern: Time to Buy?
2020-01-22,Sierra Oncology Announces Reverse Stock Split
2020-01-06,5 More Deep-Value Stocks for 2020
2019-12-19,"Here is What Hedge Funds Think About Sierra Oncology, Inc. (SRRA)"
2019-12-07,Sierra Oncology Reports Decreased Transfusion Requirements for Patients Treated with Momelotinib Directly Compared to Ruxolitinib at ASH Annual Meeting
2019-12-07,Sierra Oncology Reports Decreased Transfusion Requirements for Patients Treated with Momelotinib Directly Compared to Ruxolitinib at ASH Annual Meeting
2019-12-02,Sierra Oncology Announces Investor Event to Discuss Momelotinib Data Being Reported at ASH
2019-11-26,Sierra Oncology Announces Closing of $103 Million Public Offering and Changes to its Board of Directors
2019-11-20,Sierra Oncology Launches the MOMENTUM Phase 3 Clinical Trial for Patients with Myelofibrosis
2019-11-14,Sierra Oncology to Present at the Jefferies 2019 London Healthcare Conference
2019-11-14,Sierra Oncology to Present at the Jefferies 2019 London Healthcare Conference
2019-11-07,Sierra Oncology and Gilead Sciences Agree on Amendments to Asset Purchase Agreement for Momelotinib
2019-11-07,Sierra Oncology Announces Pricing of $103 Million Public Offering of Convertible Preferred Stock and Warrants
2019-11-07,Sierra Oncology Announces Pricing of $103 Million Public Offering of Convertible Preferred Stock and Warrants
2019-11-06,Sierra Oncology Announces Proposed Public Offering of Convertible Preferred Stock and Warrants
2019-11-06,Sierra Oncology Announces Proposed Public Offering of Convertible Preferred Stock and Warrants
2019-11-06,Sierra Oncology to Report New Analyses Supporting Momelotinib's Anemia Benefits at ASH 2019
2019-11-04,Sierra Oncology Reports Third Quarter 2019 Results
2019-11-04,Sierra Oncology Reports Third Quarter 2019 Results
2019-09-13,"Do Institutions Own Shares In Sierra Oncology, Inc. (NASDAQ:SRRA)?"
2019-08-08,Sierra Oncology Reports Second Quarter 2019 Results
2019-08-07,Sierra Oncology to Present at the Wedbush PacGrow Healthcare Conference in New York
2019-07-15,"Did Sierra Oncology, Inc. (NASDAQ:SRRA) Insiders Buy Up More Shares?"
2019-06-29,"Hedge Funds Have Never Been More Bullish On Sierra Oncology, Inc. (SRRA)"
2019-06-27,Sierra Oncology Launches Campaign Exploring Non-Dilutive Strategic Options to Support Development of its DDR Assets
2019-06-27,Sierra Oncology Launches Campaign Exploring Non-Dilutive Strategic Options to Support Development of its DDR Assets
2019-06-05,Sierra Announces Momelotinib Granted FDA Fast Track Designation
2019-06-05,Sierra Announces Momelotinib Granted FDA Fast Track Designation
2019-06-04,Sierra Announces FDA Regulatory Clarity for Momelotinib & Design of the MOMENTUM Phase 3 Clinical Trial
2019-06-04,Sierra Announces FDA Regulatory Clarity for Momelotinib & Design of the MOMENTUM Phase 3 Clinical Trial
2019-06-03,Sierra Holds Analyst & Investor Event for SRA737
2019-06-03,Sierra Holds Analyst & Investor Event for SRA737
2019-06-01,Sierra Announces Promising Preliminary Efficacy in SRA737 Clinical Program & Outlines Potential Path to Registration
2019-05-28,Sierra Oncology to Present Momelotinib and SRA737 Overview at the Jefferies Global Healthcare Conference in New York
2019-05-28,Sierra Oncology to Present Momelotinib and SRA737 Overview at the Jefferies Global Healthcare Conference in New York
2019-05-15,Sierra to Present SRA737 Preliminary Clinical Data and Potential Next Steps at ASCO
2019-05-08,"Sierra Oncology, Inc: 1Q Earnings Snapshot"
2019-05-08,Sierra Oncology Reports First Quarter 2019 Results
2019-05-08,Sierra Oncology Reports First Quarter 2019 Results
2019-05-06,Sierra Oncology to Attend Two Investor Conferences in May
2019-04-26,Imagine Owning Sierra Oncology (NASDAQ:SRRA) And Trying To Stomach The 72% Share Price Drop
2019-04-03,Sierra Reports Late-Breaking SRA141 Preclinical Data in Poster at AACR 2019
2019-04-01,Sierra Reports Late-Breaking Preclinical Data for SRA737 Presented at AACR 2019
2019-04-01,Sierra Reports Late-Breaking Preclinical Data for SRA737 Presented at AACR 2019
2019-03-05,Sierra Oncology to Present at the Cowen 39th Annual Health Care Conference in Boston
2019-02-28,Sierra Oncology Reports 2018 Year End Results
2019-02-27,Sierra Oncology Announces Late-Breaking Oral and Poster Presentations at AACR 2019 for SRA737 and SRA141 Preclinical Data
2019-01-23,Sierra Oncology to Present at the DNA Damage Response Therapeutics Summit
2019-01-22,"Do Institutions Own Sierra Oncology, Inc. (NASDAQ:SRRA) Shares?"
2018-12-03,Sierra Oncology Reports Robust Transfusion Independence Rates in Transfusion Dependent Myelofibrosis Patients Treated with Momelotinib
2018-12-03,Sierra Oncology Reports Robust Transfusion Independence Rates in Transfusion Dependent Myelofibrosis Patients Treated with Momelotinib
2018-11-29,Sierra Oncology Reports Preclinical Efficacy for Immunotherapy Combination with its Chk1 inhibitor SRA737
2018-11-27,Sierra Oncology to Host Analyst Call Highlighting Clinical Data on Momelotinib's Anemia Benefit
2018-11-22,How Does Sierra Oncology Inc (NASDAQ:SRRA) Affect Your Portfolio Volatility?
2018-11-15,Sierra Oncology Reports Preclinical Efficacy for Chk1 inhibitor SRA737 in Treatment Refractory Ovarian Cancer Models at the EORTC-NCI-AACR Symposium
